The AI in Clinical Trials Market is estimated to be worth USD 8.5 billion in 2035, predicts Roots Analysis

As a result of the excessive capital requirement and myriad of other complexities associated with clinical trials, pharmaceutical industry is increasingly relying on AI software and service providers to achieve desired outcomes

Roots Analysis is pleased to announce the publication of its recent study, titled, "AI in Clinical Trials Market"

The report features an extensive study of the current market landscape, market size and future opportunities associated with the AI in clinical trials market, during the given forecast period. Further, the report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Key takeaways of the AI in clinical trials market report includes:
1. An executive summary of the insights captured during our research.
2. A general overview of artificial intelligence in clinical trials, highlighting details on artificial intelligence and its subfields.
3. A detailed assessment of the current market landscape of the companies offering AI software and service for clinical trials, based on several relevant parameters.
4. Elaborate profiles of the prominent companies (shortlisted based on a proprietary criterion) developing AI software / AI solutions and offering services for clinical trials.
5. An insightful clinical trial analysis of completed / ongoing clinical trials leveraging AI, based on various relevant parameters.
6. A detailed analysis of the partnerships inked between stakeholders in the AI in clinical trials market, since 2018.
7. An analysis of the investments made, including seed financing, venture capital financing, capital raised from IPOs, grants, debt financing and other equity, and subsequent offerings.
8. A detailed analysis of the initiatives taken by big pharma players related to AI in clinical trials, based on various relevant parameters.
9. An insightful framework depicting the implementation of several advanced tools and technologies, such as blockchain, big data analytics, real-world evidence, digital twins, cloud computing and internet of things (IoT) at different steps of a clinical study.
10. A detailed cost saving analysis, highlighting the overall cost saving potential of AI in clinical trials till 2035.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/ai-based-clinical-trial-solutions/request-quote.html

11. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Trial Phase
a) Phase I
b) Phase II
c) Phase III
Target Therapeutic Area
a) Oncological Disorders
b) Cardiovascular Disorders
c) CNS Disorders
d) Infectious Diseases
e) Metabolic Disorders
f) Other Disorders

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/ai-based-clinical-trial-solutions/request-sample.html

End-User
a) Biotechnology and Pharmaceutical Companies
b) Academic Research Institute and Other end-users

Key Geographical Region
a) North America
b) Europe
c) Asia-Pacific
d) Middle East and North Africa
e) Latin America

Key companies covered in the report
a) AiCure
b) Antidote Technologies
c) Deep 6 AI
d) Innoplexus
e) IQVIA
f) Median Technologies
g) Medidata
h) Mendel.ai
i) Phesi
j) Saama Technologies
k) Signant Health
l) Trials.ai

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/ai-based-clinical-trial-solutions.html

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.